XAV939,
XAV-939,
284028-89-3,
XAV939,
XAV 939,
3,5,7,8-Tetrahydro-2-[4-(trifluoromethyl)phenyl]-4H-thiopyrano[4,3-d]pyrimidin-4-one,
CHEBI:62878,
NVP-XAV 939,
CHEMBL1086580,
2-(4-(trifluoromethyl)phenyl)-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-4-ol,
MFCD16879017,
2-[4-(trifluoromethyl)phenyl]-1,5,7,8-tetrahydrothiopyrano[4,3-d]pyrimidin-4-one,
2-[4-(trifluoromethyl)phenyl]-7,8-dihydro-5H-thiino[4,3-d]pyrimidin-4-ol,
2-[4-(Trifluoromethyl)phenyl]-7,8-Dihydro-5h-Thiopyrano[4,3-D]pyrimidin-4-Ol,
C14H11F3N2OS,
2-(4-(trifluoromethyl)phenyl)-1,5,7,8-tetrahydro-4H-thiopyrano[4,3-d]pyrimidin-4-one,
2-[4-(Trifluoromethyl)phenyl]-1,5,7,8-tetrahydro-4H-thiopyrano[4,3-d]pyrimidin-4-one,
XAV,
3kr8,
3uh4,
AC1MBK2K,
Maybridge3_005018,
NVP-XAV939,
MLS006012021,
SCHEMBL7783488,
SCHEMBL15315468,
AOB4150,
DTXSID60369423,
XAV939,XAV-939,
BCPP000009,
HMS1445E02,
HMS3648B17,
HMS3654O16,
HMS3678D07,
XAV939, XAV-939,
BCP02128,
EX-A1760,
ABP000288,
BDBM50188594,
BDBM50318567,
BS0283,
s1180,
ZINC13467799,
AKOS015954858,
AKOS024457786,
AKOS026750243,
CCG-208105,
CS-0494,
MCULE-6143908878,
RL02965,
SB19432,
IDI1_016405,
KS-0000181U,
NCGC00250397-01,
NCGC00484998-01,
AC-28393,
AK198691,
AN-16908,
CS-10386,
HY-15147,
SC-95571,
SMR003874205,
XAV 939/XAV939,NVP-XAV939,
XAV939, >=98% (HPLC),
DB-067924,
FT-0675873,
SW218311-2,
X7558,
A25698,
W-5666,
SR-01000946403,
J-511234,
SR-01000946403-1,
BRD-K12762134-001-01-3,
BRD-K12762134-001-05-4,
2-[4-(trifluoromethyl)phenyl]-5H,7H,8H-thiopyrano[4,3-d]pyrimidin-4-ol,
6,8-Dihydro-2-[4-(trifluoromethyl)phenyl]-5H-thiopyrano[3,4-d]pyrimidine,
1,5,7,8-Tetrahydro-2-[4-(trifluoromethyl)phenyl]-4H-thiopyrano[4,3-d]pyrimidin-4-one,
2-(4-(trifluoromethyl)phenyl)-7,8-dihydro-1H-thiopyrano[4,3-d]pyrimidin-4(5H)-one,
2-(4-(trifluoromethyl)phenyl)-7,8-dihydro-3H-thiopyrano[4,3-d]pyrimidin-4(5H)-one,
2-(4-(Trifluoromethyl)phenyl)-7,8-dihydro-5H-thiopyrano-[4,3-d]pyrimidin-4-ol,
2-(4-Trifluoromethyl-phenyl)-3,5,7,8-tetrahydro-thiopyrano[4,3-d]pyrimidin-4-one,
2-[4-(trifluoromethyl)phenyl]-1H,4H,5H,7H,8H-thiopyrano[4,3-d]pyrimidin-4-one,
NVP-XAV939;3,5,7,8-Tetrahydro-2-[4-(trifluoromethyl)phenyl]-4H-thiopyrano[4,3-d]pyrimidin-4-one,
cc-343,
KLGQSVMIPOVQAX-UHFFFAOYSA-N,
CCG 1423,
ZINC00077297,
CID2726824,
A1877,
X0077,
A10994,
C544261,
285986-88-1,
3,5,7,8-TETRAHYDRO-2-[4-(TRIFLUOROMETHYL)PHENYL]-4H-THIOPYRANO[4,3-D]PYRIMIDIN-4-OL,
XAV-939, 98%, a selective Wnt pathway beta-catenin-mediated transcription inhibitor - 100MG 100mg,